Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Cynthia Comella, Joseph Jankovic, Robert A. Hauser, et al.
Neurology (2024) Vol. 102, Iss. 4
Open Access | Times Cited: 12

Showing 12 citing articles:

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information
Khashayar Dashtipour, Han S. Lee, Aaron Ellenbogen, et al.
Toxins (2024) Vol. 16, Iss. 10, pp. 442-442
Open Access | Times Cited: 4
Clinical response to placebo botulinum toxin injection in cervical dystonia—a systematic review and meta-analysis
Emma Wetmore, Henry Roberts, Alicia A. Livinski, et al.
Dystonia (2025) Vol. 4
Open Access
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA
Aaron Ellenbogen, Robert A. Hauser, Atul T. Patel, et al.
Toxins (2025) Vol. 17, Iss. 3, pp. 133-133
Open Access
Comment on Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. Toxins 2024, 16, 442
Richard Trosch, Daniel Parreirinha, Susanne Proeschel
Toxins (2025) Vol. 17, Iss. 4, pp. 190-190
Open Access
Efficacy and Safety of Daxibotulinumtoxina in Adults with Cervical Dystonia: Pooled Global Analysis of ASPEN-1 and ASPEN-1-CN Randomized Trials
Aaron Ellenbogen, Xingyue Hu, Lingjing Jin, et al.
(2025)
Closed Access
Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm
Michael A. Hast, Amanda M. Kong, Shaina Desai, et al.
Toxins (2024) Vol. 16, Iss. 8, pp. 362-362
Open Access | Times Cited: 2
Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
Anna Castagna, Hyder A. Jinnah, Alberto Albanese
Parkinsonism & Related Disorders (2024) Vol. 125, pp. 107011-107011
Closed Access | Times Cited: 1
Current use of neurotoxins for alleviating symptoms of cervical dystonia
Stephen Aradi, Robert A. Hauser
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access
A digital patient-centered outcome tool for cervical dystonia
Sarah Pirio Richardson, Brian D. Berman, Janet Hieshetter, et al.
Dystonia (2024) Vol. 3
Open Access
Dosing Dilemma: Can Reduced Botulinum Neurotoxin Type-A Doses Offer Longer-Lasting Effects in Cervical Dystonia?
Avery Kundrick, Claire Sonneborn, Hubert H. Fernandez
Parkinsonism & Related Disorders (2024) Vol. 130, pp. 107209-107209
Closed Access
Zervikale Dystonie: Neue Botox-Typ-A-Formulierung ist sicher und wirksam

Fortschritte der Neurologie · Psychiatrie (2024) Vol. 92, Iss. 12, pp. 490-491
Closed Access
Successful Treatment of Severe, Poorly Controlled Benign Essential Blepharospasm with DaxibotulinumtoxinA
Marissa K. Shoji, Suzan Sargsyan, Eman Al-Sharif, et al.
Ophthalmic Plastic and Reconstructive Surgery (2024)
Closed Access
Exploring New and Potential Indications for Botulinum Toxin Treatment: An Updated Literature Review
Jimmy Wen, Dawnica Nadora, Ubaid Ansari, et al.
Cureus (2024)
Open Access
Page 1

Scroll to top